{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:03:57Z","timestamp":1785888237589,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Unexplained infertility accounts for 25% of infertility causes in the UK. Active intervention methods, such as intrauterine insemination (IUI) or in vitro fertilisation (IVF), are often sought. Despite the National Institute for Health and Care Excellence (NICE) recommending IVF for unexplained infertility, this recommendation has generated an ongoing debate, with few fertility clinics discontinuing the use of IUI as the first-line management of choice. In contrast to NICE, recent guidance released from the European Society for Human Reproduction and Embryology (ESHRE) in August 2023 supports the use of IUI as first-line. High-quality evidence behind such interventions is lacking, with current literature providing conflicting results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>This review aims to provide a literature overview exploring whether IUI or IVF should be used as first-line treatment for couples with unexplained infertility, in the context of current guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The primary outcome used to assess efficacy of both treatment methods is live birth (LB) rates. Secondary outcomes used are clinical pregnancy (CP) and ongoing pregnancy (OP) rates. A comprehensive literature search of 4 databases: Ovid MEDLINE, EMBASE, Maternity &amp; Infant Care and the Cochrane Library were searched in January 2022. Upon removal of duplications, abstract screening, and full-text screening, a total of 34 papers were selected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion\/conclusion<\/jats:title>\n                <jats:p>This review highlights a large discrepancy in the literature when examining pregnancy outcomes of IUI and IVF treatments. Evidence shows IUI increases LB and CP rates 3-fold compared to expectant management. Literature comparing IUI to IVF is less certain. The review finds the literature implies IVF should be used for first-line management but the paucity of high-quality randomised controlled trials (RCTs), coupled with heterogeneity of the identified studies and a lack of research amongst women\u2009&gt;\u200940 years warrants the need for further large RCTs. The decision to offer IUI with ovarian stimulation (IUI-OS) or IVF should be based upon patient prognostic factors. We suggest that IUI-OS could be offered as first-line treatment for unexplained infertility for women\u2009&lt;\u200938 years, with good prognosis, and IVF could be offered first to those\u2009&gt;\u200938 years. Patients should be appropriately counselled to enable informed decision making.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02717-1","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:31:59Z","timestamp":1698438719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Should IUI replace IVF as first-line treatment for unexplained infertility? A literature review"],"prefix":"10.1186","volume":"23","author":[{"given":"Jessica Ka-Yan","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Elizabeth","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Ikhlaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mausumi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"key":"2717_CR1","unstructured":"National Institute for Health and Care Excellence (NICE), Fertility problems: assessment and treatment: Clinical Guideline [CG156]https:\/\/www.nice.org.uk\/guidance\/cg156] [Accessed Jan 14, 2022]."},{"issue":"2","key":"2717_CR2","first-page":"69","volume":"1","author":"A Quaas","year":"2008","unstructured":"Quaas A, Dokras A. Diagnosis and treatment of unexplained infertility. Reviews in Obstetrics and Gynecology. 2008;1(2):69\u201376. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2505167\/].","journal-title":"Reviews in Obstetrics and Gynecology"},{"key":"2717_CR3","unstructured":"World Health Organization. Infertilityhttps:\/\/www.who.int\/news-room\/fact-sheets\/detail\/infertility] [Accessed Jan 24, 2022]."},{"key":"2717_CR4","unstructured":"National Institute for Health and Care Excellence (NICE), Addendum to Clinical Guideline 156, Fertility problems: assessment and treatment: Clinical Guideline Addendum 156.1https:\/\/www.nice.org.uk\/guidance\/cg156\/evidence\/addendum-pdf-2606775661] [Accessed Jan 14, 2022]."},{"issue":"1","key":"2717_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/14647273.2014.948081","volume":"18","author":"A Nandi","year":"2015","unstructured":"Nandi A, Gudi A, Shah A, Homburg R. An online survey of specialists\u2019 opinion on first line management options for unexplained subfertility. Hum Fertility. 2015;18(1):48\u201353. https:\/\/doi.org\/10.3109\/14647273.2014.948081].","journal-title":"Hum Fertility"},{"issue":"3","key":"2717_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/humupd\/dmx041","volume":"24","author":"B Cohlen","year":"2018","unstructured":"Cohlen B, Bijkerk A, Van der Poel S, Ombelet W. IUI: review and systematic assessment of the evidence that supports global recommendations. Hum Reprod Update. 2018;24(3):300\u201319. https:\/\/doi.org\/10.1093\/humupd\/dmx041].","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2717_CR7","doi-asserted-by":"publisher","first-page":"CD001838","DOI":"10.1002\/14651858.CD001838.pub6","volume":"3","author":"RO Ayeleke","year":"2020","unstructured":"Ayeleke RO, Asseler JD, Cohlen BJ, Veltman-Verhulst SM. Intra\u2010uterine insemination for unexplained subfertility. Cochrane Database of Systematic Reviews. 2020;3(3):CD001838. https:\/\/doi.org\/10.1002\/14651858.CD001838.pub6].","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"2717_CR8","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/humrep\/dew241","volume":"31","author":"RI Tjon-Kon-Fat","year":"2016","unstructured":"Tjon-Kon-Fat RI, Bensdorp AJ, Scholten I, Repping S, van Wely M, Mol BWJ, et al. IUI and IVF for unexplained subfertility: where did we go wrong? Hum Reprod (Oxford England). 2016;31(12):2665\u20137. https:\/\/doi.org\/10.1093\/humrep\/dew241].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"9","key":"2717_CR9","doi-asserted-by":"publisher","first-page":"CD012692","DOI":"10.1002\/14651858.CD012692.pub2","volume":"2019","author":"R Wang","year":"2019","unstructured":"Wang R, Danhof NA, Tjon-Kon\u2010Fat RI, Eijkemans MJ, Bossuyt PM, Mochtar MH, et al. Interventions for unexplained infertility: a systematic review and network meta\u2010analysis. Cochrane Database Syst Rev. 2019;2019(9):CD012692. https:\/\/doi.org\/10.1002\/14651858.CD012692.pub2].","journal-title":"Cochrane Database Syst Rev"},{"key":"2717_CR10","doi-asserted-by":"publisher","unstructured":"Romualdi D, Ata B, Bhattacharya S, Bosch E, Costello M, Gersak K, et al. Evidence-based guideline: unexplained infertility. Hum Reprod (Oxford England). 2023;dead150. https:\/\/doi.org\/10.1093\/humrep\/dead150].","DOI":"10.1093\/humrep\/dead150"},{"key":"2717_CR11","unstructured":"Guideline Group on Unexplained Infertility, Romualdi D, Ata B, Bhattacharya S, Bosch E, Costello M et al. Evidence-based guideline: Unexplained Infertilityhttps:\/\/www.eshre.eu\/-\/media\/sitecore-files\/Guidelines\/UI\/UI-guideline_-Final.pdf] [Accessed Sep 10, 2023]."},{"issue":"2","key":"2717_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humrep\/deg081","volume":"18","author":"JA Land","year":"2003","unstructured":"Land JA, Evers JLH. Risks and Complications in assisted reproduction techniques: report of an ESHRE consensus meeting. Hum Reprod (Oxford England). 2003;18(2):455\u20137. https:\/\/doi.org\/10.1093\/humrep\/deg081].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"5","key":"2717_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.fertnstert.2014.03.026","volume":"101","author":"KT Barnhart","year":"2014","unstructured":"Barnhart KT. Live birth is the correct outcome for clinical trials evaluating therapy for the infertile couple. Fertil Steril. 2014;101(5):1205\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.026].","journal-title":"Fertil Steril"},{"issue":"6","key":"2717_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.fertnstert.2020.10.029","volume":"114","author":"W Ombelet","year":"2020","unstructured":"Ombelet W, van Eekelen R, McNally A, Ledger W, Doody K, Farquhar C. Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment? Fertil Steril. 2020;114(6):1141\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.10.029].","journal-title":"Fertil Steril"},{"key":"2717_CR15","unstructured":"Human F, Embryology Authority. &. Fertility treatment 2019: trends and figures | HFEAhttps:\/\/www.hfea.gov.uk\/about-us\/publications\/research-and-data\/fertility-treatment-2019-trends-and-figures\/] [Accessed Jan 14, 2022]."},{"issue":"6","key":"2717_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/humrep\/dez049","volume":"34","author":"DJ McLernon","year":"2019","unstructured":"McLernon DJ, Lee AJ, Maheshwari A, van Eekelen R, van Geloven N, Putter H, et al. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility. Hum Reprod (Oxford England). 2019;34(6):1126\u201338. https:\/\/doi.org\/10.1093\/humrep\/dez049].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"10119","key":"2717_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0140-6736(17)32406-6","volume":"391","author":"CM Farquhar","year":"2018","unstructured":"Farquhar CM, Liu E, Armstrong S, Arroll N, Lensen S, Brown J. Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet (London England). 2018;391(10119):441\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(17)32406-6].","journal-title":"Lancet (London England)"},{"issue":"3","key":"2717_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/01443615.2021.1916805","volume":"42","author":"\u015e Osmanl\u0131o\u011flu","year":"2022","unstructured":"Osmanl\u0131o\u011flu \u015e, \u015e\u00fck\u00fcr YE, Tokg\u00f6z VY, \u00d6zmen B, S\u00f6nmezer M, Berker B, et al. Intrauterine insemination with ovarian stimulation is a successful step prior to assisted reproductive technology for couples with unexplained infertility. J Obstet Gynaecology: J Inst Obstet Gynecol. 2022;42(3):472\u20137. https:\/\/doi.org\/10.1080\/01443615.2021.1916805].","journal-title":"J Obstet Gynaecology: J Inst Obstet Gynecol"},{"key":"2717_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejogrb.2017.01.016","volume":"210","author":"ME Geisler","year":"2017","unstructured":"Geisler ME, Ledwidge M, Bermingham M, McAuliffe M, McMenamin MB, Waterstone JJ. Intrauterine insemination-No more Mr. N.I.C.E. guy? Eur J Obstet Gynecol Reprod Biol. 2017;210:342\u20137. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.016].","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"2717_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.23736\/S0026-4784.17.04085-0","volume":"69","author":"A Ohannessian","year":"2017","unstructured":"Ohannessian A, Loundou A, Gnisci A, Paulmyer-Lacroix O, Perrin J, Courbiere B. Unexplained infertility: live-birth\u2019s prognostic factors to determine the ART management. Minerva Ginecol. 2017;69(6):526\u201332. https:\/\/doi.org\/10.23736\/S0026-4784.17.04085-0].","journal-title":"Minerva Ginecol"},{"issue":"3","key":"2717_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijgo.2010.10.017","volume":"112","author":"LR Christie","year":"2011","unstructured":"Christie LR, Harriott JA, Dacosta VE, Wynter SH, Everett DM, Foster RA. Intrauterine insemination in Jamaica as a low-cost subfertility treatment in a low-resource region. Int J Gynaecol Obstet. 2011;112(3):208\u201310. https:\/\/doi.org\/10.1016\/j.ijgo.2010.10.017].","journal-title":"Int J Gynaecol Obstet"},{"key":"2717_CR22","doi-asserted-by":"publisher","unstructured":"Ganguly I, Singh A, Bhandari S, Agrawal P, Gupta N. Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study. International Journal of Reproductive Medicine 2016; 2016 5817823. https:\/\/doi.org\/10.1155\/2016\/5817823].","DOI":"10.1155\/2016\/5817823"},{"issue":"1","key":"2717_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/humrep\/dey329","volume":"34","author":"R van Eekelen","year":"2019","unstructured":"van Eekelen R, van Geloven N, van Wely M, McLernon DJ, Mol F, Custers IM, et al. Is IUI with ovarian stimulation effective in couples with unexplained subfertility? Hum Reprod (Oxford England). 2019;34(1):84\u201391. https:\/\/doi.org\/10.1093\/humrep\/dey329].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"2","key":"2717_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.rbmo.2011.11.007","volume":"24","author":"A Wiser","year":"2012","unstructured":"Wiser A, Shalom-Paz E, Reinblatt SL, Son W, Das M, Tulandi T, et al. Ovarian stimulation and intrauterine insemination in women aged 40 years or more. Reprod Biomed Online. 2012;24(2):170\u20133. https:\/\/doi.org\/10.1016\/j.rbmo.2011.11.007].","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2717_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/humrep\/der389","volume":"27","author":"IM Custers","year":"2012","unstructured":"Custers IM, van Rumste MME, van der Steeg JW, van Wely M, Hompes PGA, Bossuyt P, et al. Long-term outcome in couples with unexplained subfertility and an intermediate prognosis initially randomized between expectant management and immediate treatment. Hum Reprod (Oxford England). 2012;27(2):444\u201350. https:\/\/doi.org\/10.1093\/humrep\/der389].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"1","key":"2717_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10815-017-1021-4","volume":"35","author":"JB Babigumira","year":"2018","unstructured":"Babigumira JB, Sharara FI, Garrison Louis P Jr. Projecting the potential impact of the Cap-Score\u2122 on clinical pregnancy, live births, and medical costs in couples with unexplained infertility | journal of assisted Reproduction and Genetics. J Assist Reprod Genet. 2018;35(1):99\u2013106. https:\/\/doi.org\/10.1007\/s10815-017-1021-4].","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"2717_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.fertnstert.2014.01.009","volume":"101","author":"L Dinelli","year":"2014","unstructured":"Dinelli L, Courbi\u00e8re B, Achard V, Jouve E, Deveze C, Gnisci A, et al. Prognosis factors of pregnancy after intrauterine insemination with the husband\u2019s sperm: conclusions of an analysis of 2,019 cycles. Fertil Steril. 2014;101(4):994\u20131000. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.01.009].","journal-title":"Fertil Steril"},{"issue":"3","key":"2717_CR28","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.fertnstert.2019.10.034","volume":"113","author":"ET Wang","year":"2020","unstructured":"Wang ET, Diamond MP, Alvero R, Casson P, Christman GM, Coutifaris C, et al. Androgenicity and fertility treatment in women with unexplained infertility. Fertil Steril. 2020;113(3):636\u201341. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.10.034].","journal-title":"Fertil Steril"},{"issue":"6","key":"2717_CR29","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/humrep\/deu069","volume":"29","author":"M Braakhekke","year":"2014","unstructured":"Braakhekke M, Kamphuis EI, van Rumste MM, Mol F, van der Veen F, Mol BW. How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine? Hum Reprod (Oxford England). 2014;29(6):1211\u20137. https:\/\/doi.org\/10.1093\/humrep\/deu069].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"5","key":"2717_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.fertnstert.2014.03.047","volume":"101","author":"M Braakhekke","year":"2014","unstructured":"Braakhekke M, Kamphuis EI, Dancet EA, Mol F, van der Veen F, Mol BW. Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper. Fertil Steril. 2014;101(5):1203\u20134. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.047].","journal-title":"Fertil Steril"},{"issue":"3","key":"2717_CR31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.fertnstert.2009.04.022","volume":"94","author":"RH Reindollar","year":"2010","unstructured":"Reindollar RH, Regan MM, Neumann PJ, Levine B, Thornton KL, Alper MM, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil Steril. 2010;94(3):888\u201399. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.04.022].","journal-title":"Fertil Steril"},{"issue":"1","key":"2717_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.fertnstert.2021.09.012","volume":"117","author":"DA Vaughan","year":"2022","unstructured":"Vaughan DA, Goldman MB, Koniares KG, Nesbit CB, Toth TL, Fung JL, et al. Long-term reproductive outcomes in patients with unexplained infertility: follow-up of the fast track and Standard Treatment Trial participants. Fertil Steril. 2022;117(1):193\u2013201. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.09.012].","journal-title":"Fertil Steril"},{"issue":"3","key":"2717_CR33","doi-asserted-by":"publisher","first-page":"E261","DOI":"10.1016\/j.fertnstert.2020.08.726","volume":"114","author":"DA Vaughan","year":"2020","unstructured":"Vaughan DA, Goldman MB, Fung JL, Koniares KG, Nesbit CB, Toth TL, et al. Long Term follow up of Reproductive outcomes in FASTT participants. Fertil Steril. 2020;114(3):E261. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.08.726].","journal-title":"Fertil Steril"},{"issue":"6","key":"2717_CR34","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.fertnstert.2014.03.012","volume":"101","author":"MB Goldman","year":"2014","unstructured":"Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the forty and over treatment trial (FORT-T). Fertil Steril. 2014;101(6):1574\u20132. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.012].","journal-title":"Fertil Steril"},{"issue":"1","key":"2717_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5935\/1518-0557.20210038","volume":"26","author":"AS Mendieta MAd, Aranda","year":"2022","unstructured":"Mendieta MAd, Aranda AS, L\u00f3pez JFM, S\u00e1nchez AMR, Mondrag\u00f3n EC, Monterrosas L\u00c1D, et al. Comparative analysis of the pregnancy rate via in vitro fertilization vs. previous artificial insemination in patients with unexplained infertility. JBRA Assist Reprod. 2022;26(1):22\u20137. https:\/\/doi.org\/10.5935\/1518-0557.20210038].","journal-title":"JBRA Assist Reprod"},{"key":"2717_CR36","unstructured":"Pacu I, Ionescu C, Dimitriu M, Banacu M, Tarcomnicu IM, C\u0103lin D et al. Intrauterine insemination in idiopathic infertility. Archives of the Balkan Medical Union 2016; 51: 334\u2013339. https:\/\/www.researchgate.net\/publication\/313047153_Intrauterine_insemination_in_idiopathic_infertility]. [Accessed 14 January 2022]."},{"issue":"2","key":"2717_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ajo.12168","volume":"54","author":"H Elzeiny","year":"2014","unstructured":"Elzeiny H, Garrett C, Toledo M, Stern K, McBain J, Baker HWG. A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility. Aust N Z J Obstet Gynaecol. 2014;54(2):156\u201361. https:\/\/doi.org\/10.1111\/ajo.12168].","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"2717_CR38","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00404-021-06351-w","volume":"305","author":"P Merviel","year":"2022","unstructured":"Merviel P, Labarre M, James P, Bou\u00e9e S, Chabaud J, Roche S, et al. Should intrauterine inseminations still be proposed in cases of unexplained infertility? Retrospective study and literature review. Arch Gynecol Obstet. 2022;305(5):1241\u201354. https:\/\/doi.org\/10.1007\/s00404-021-06351-w].","journal-title":"Arch Gynecol Obstet"},{"key":"2717_CR39","doi-asserted-by":"publisher","first-page":"768975","DOI":"10.3389\/fendo.2021.768975","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Liu H, Liu J. The Livebirth Rate Per in Vitro Fertilization cycle is higher than the Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 with unexplained infertility. Front Endocrinol. 2021;12:768975. https:\/\/doi.org\/10.3389\/fendo.2021.768975].","journal-title":"Front Endocrinol"},{"issue":"10","key":"2717_CR40","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1093\/humrep\/dev193","volume":"30","author":"RI Tjon-Kon-Fat","year":"2015","unstructured":"Tjon-Kon-Fat RI, Bensdorp AJ, Bossuyt PMM, Koks C, Oosterhuis GJE, Hoek A, et al. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation? Hum Reprod (Oxford England). 2015;30(10):2331\u20139. https:\/\/doi.org\/10.1093\/humrep\/dev193].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"3","key":"2717_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.rbmo.2013.10.021","volume":"28","author":"MME van Rumste","year":"2014","unstructured":"van Rumste MME, Custers IM, van Wely M, Koks CA, van Weering HGI, Beckers NGM, et al. IVF with planned single-embryo transfer versus IUI with ovarian stimulation in couples with unexplained subfertility: an economic analysis. Reprod Biomed Online. 2014;28(3):336\u201342. https:\/\/doi.org\/10.1016\/j.rbmo.2013.10.021].","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"2717_CR42","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/humrep\/dex037","volume":"32","author":"RI Tjon-Kon-Fat","year":"2017","unstructured":"Tjon-Kon-Fat RI, Tajik P, Zafarmand MH, Bensdorp AJ, Bossuyt PMM, Oosterhuis GJE, et al. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers. Hum Reprod (Oxford England). 2017;32(5):1028\u201332. https:\/\/doi.org\/10.1093\/humrep\/dex037].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"6","key":"2717_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.fertnstert.2017.03.028","volume":"107","author":"A Nandi","year":"2017","unstructured":"Nandi A, Bhide P, Hooper R, Gudi A, Shah A, Khan K, et al. Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial. Fertil Steril. 2017;107(6):1329\u20131335e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.03.028].","journal-title":"Fertil Steril"},{"key":"2717_CR44","doi-asserted-by":"publisher","unstructured":"Bensdorp AJ, Tjon-Kon-Fat RI, Bossuyt PMM, Koks CM, Oosterhuis GJE, Hoek A, et al. Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterine insemination with controlled ovarian hyperstimulation. BMJ (Clinical Research ed). 2015;350g7771. https:\/\/doi.org\/10.1136\/bmj.g7771].","DOI":"10.1136\/bmj.g7771"},{"issue":"7","key":"2717_CR45","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/humrep\/dex096","volume":"32","author":"SS Malchau","year":"2017","unstructured":"Malchau SS, Henningsen AA, Loft A, Rasmussen S, Forman J, Nyboe Andersen A, et al. The long-term prognosis for live birth in couples initiating fertility treatments. Hum Reprod (Oxford England). 2017;32(7):1439\u201349. https:\/\/doi.org\/10.1093\/humrep\/dex096].","journal-title":"Hum Reprod (Oxford England)"},{"issue":"4","key":"2717_CR46","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00404-021-06277-3","volume":"305","author":"A Nandi","year":"2022","unstructured":"Nandi A, Raja G, White D, Tarek E. Intrauterine insemination + controlled ovarian hyperstimulation versus in vitro fertilisation in unexplained infertility: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022;305(4):805\u201324. https:\/\/doi.org\/10.1007\/s00404-021-06277-3].","journal-title":"Arch Gynecol Obstet"},{"key":"2717_CR47","doi-asserted-by":"publisher","unstructured":"Rake J, Mochtar M, Van Putten E, Van Wely M, P-789. Unexplained subfertility in women aged 38 years and above: could intrauterine insemination be an alternative for in vitro fertilization? A systematic review and meta-analysis. Hum Reprod. 2023;38(Supplement 1). https:\/\/doi.org\/10.1093\/humrep\/dead093.144]. dead093.144.","DOI":"10.1093\/humrep\/dead093.144"},{"issue":"2","key":"2717_CR48","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/humrep\/deq349","volume":"26","author":"M Brandes","year":"2011","unstructured":"Brandes M, Hamilton CJCM, van der Steen JOM, de Bruin JP, Bots RSGM, Nelen WLDM, et al. Unexplained infertility: overall ongoing pregnancy rate and mode of conception. Hum Reprod (Oxford England). 2011;26(2):360\u20138. https:\/\/doi.org\/10.1093\/humrep\/deq349].","journal-title":"Hum Reprod (Oxford England)"},{"key":"2717_CR49","doi-asserted-by":"crossref","unstructured":"Smith JF, Eisenberg ML, Millstein SG, Nachtigall RD, Sadetsky N, Cedars MI et al. Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States. Fertility and Sterility 2011; 95 (1): 79\u201384. https:\/\/doi.org\/1016\/j.fertnstert.2010.06.043.","DOI":"10.1016\/j.fertnstert.2010.06.043"},{"key":"2717_CR50","doi-asserted-by":"publisher","unstructured":"Pandian Z, Gibreel A, Bhattacharya S. In vitro fertilisation for unexplained subfertility. Cochrane Database of Systematic Reviews. 2015;11CD003357. https:\/\/doi.org\/10.1002\/14651858.CD003357.pub4].","DOI":"10.1002\/14651858.CD003357.pub4"},{"issue":"5","key":"2717_CR51","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.fertnstert.2011.08.005","volume":"96","author":"IM Custers","year":"2011","unstructured":"Custers IM, K\u00f6nig TE, Broekmans FJ, Hompes PGA, Kaaijk E, Oosterhuis J, et al. Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation. Fertil Steril. 2011;96(5):1107\u20131111e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.08.005].","journal-title":"Fertil Steril"},{"issue":"8","key":"2717_CR52","doi-asserted-by":"publisher","first-page":"101831","DOI":"10.1016\/j.jogoh.2020.101831","volume":"49","author":"C Verhaeghe","year":"2020","unstructured":"Verhaeghe C, Abnoun S, May-Panloup P, Corroenne R, Legendre G, Descamps P, et al. Conversion of in vitro fertilization cycles to intrauterine inseminations in patients with a poor ovarian response: risk of multiple pregnancies. J Gynecol Obstet Hum Reprod. 2020;49(8):101831. https:\/\/doi.org\/10.1016\/j.jogoh.2020.101831].","journal-title":"J Gynecol Obstet Hum Reprod"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02717-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T20:32:20Z","timestamp":1698438740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02717-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2717"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02717-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"557"}}